James Budge - 29 Apr 2025 Form 4 Insider Report for Hinge Health, Inc. (HNGE)

Reporting relationship: Chief Financial Officer
Issuer ticker: HNGE
Reported as of: 29 Apr 2025
Net transaction value: -$4,322,240
SEC form: 4
Accepted by SEC: 23 May 2025, 17:21:50 UTC
Next SEC filing: 21 May 2025
Source filing: View source filing
Reporting owner signature: /s/ David Wood, Attorney-in-Fact

Key filing fact

James Budge filed Form 4 for Hinge Health, Inc. (HNGE) on 23 May 2025.

Key facts

This page summarizes James Budge's Form 4 filing for Hinge Health, Inc. (HNGE).
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 23 May 2025, 17:21.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: -$4,322,240.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001338176 Primary reporting owner

Budge James

Relationship: Chief Financial Officer
Address: C/O HINGE HEALTH, INC., 455 MARKET STREET, SUITE 700, SAN FRANCISCO
Signature: /s/ David Wood, Attorney-in-Fact
Signature date: 23 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HNGE transaction

Common Stock

Award

Transaction value: $0
Shares: +91,875
Change %: +15%
Price: $0.000000
Shares after: 694,440
Date: 29 Apr 2025
Ownership: Direct
Footnotes: F1, F2

HNGE transaction

Common Stock

Tax liability

Transaction value: $4,322,240
Shares: -135,070
Change %: -19%
Price: $32.00
Shares after: 559,370
Date: 21 May 2025
Ownership: Direct

HNGE transaction

Common Stock

Other

Transaction value
Shares: -559,370
Change %: -100%
Price
Shares after: 0
Date: 23 May 2025
Ownership: Direct
Footnotes: F3

HNGE transaction

Class A Common Stock

Other

Transaction value
Shares: +559,370
Change %
Price
Shares after: 559,370
Date: 23 May 2025
Ownership: Direct
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Reflects an award of restricted stock units ("RSUs"), which vests as to 3.125% of the total award each quarter for the first two years, and as to 9.375% of the total award each quarter thereafter until fully vested at the fourth anniversary of the vesting commencement date. Each RSU represents a contingent right to receive one share of Class A Common Stock following the reclassification of the Issuer's Common Stock.

Footnote F2

These securities were previously reported on a Form 3 filed by the Reporting Person.

Footnote F3

Immediately prior to the completion of the Issuer's initial public offering, each share of Common Stock (other than those held by the Issuer's founders and certain related individuals), including shares of Common Stock underlying RSU awards, were reclassified into one share of Class A Common Stock in an exempt transaction pursuant to Rule 16b-7.

Footnote F4

Includes 387,084 RSUs, which vest in accordance with the terms of the award. Each RSU represents a contingent right to receive one share of Class A Common Stock.